![Rick Fletcher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rick Fletcher
Geen lopende functies
Profiel
Rick Fletcher has been Vice President of Regulatory Compliance and Quality Systems for Cepheid since joining the company in April 2007.
Prior to joining Cepheid, Mr. Fletcher was Director of Molecular Diagnostics Operations for Veridex LLC.
He held various positions at Gen-Probe, Roche Molecular Systems, ID Biomedical, Amersham Pharmacia, Johnson & Johnson Clinical Diagnostics and Biosense Webster.
Mr. Fletcher has more than 20 years of experience in the clinical diagnostic industry in the areas of R&D, Quality Control, Operations and Quality Assurance.
Eerdere bekende functies van Rick Fletcher
Bedrijven | Functie | Einde |
---|---|---|
Veridex LLC
![]() Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
CEPHEID | Algemeen Adviseur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
CEPHEID
![]() CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
Veridex LLC
![]() Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Health Technology |